Atrasentan salt hydrate InChi: InChI=1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16

InChi: InChI=1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16

Formula: C9H10Cl3N3

Muscarinic agonists in sufficient dosage can increase secretion of exocrine glands

5-Arylamino-2-methyl-4

27(9):1685-95

Atrasentan salt hydrate InChi: InChI=1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16Atrasentan is designed to block the action of endothelin 1; for treating metastatic hormone refractory prostate cancer. Product information CAS Number: 173937 91 2 Molecular Weight: 510. 62 Formula: C29H38N2O6 Chemical Name: (2R,3R,4S) 4 (2H 1,3 benzodioxol 5 yl) 1 [(dibutylcarbamoyl)methyl] 2 (4 methoxyphenyl)pyrrolidine 3 carboxylic acid Smiles: COC1C=CC(=CC=1)[C@H]1[C@@H]([C@H](CN1CC(=O)N(CCCC)CCCC)C1=CC2OCOC=2C=C1)C(O)=O InChiKey: MOTJMGVDPWRKOC